TPWA
BIIB icon

Twin Peaks Wealth Advisors’s Biogen BIIB Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.3K Buy
+127
New +$23.4K 0.01% 657
2025
Q3 		– Sell
-70
Closed -$9.03K – 401
2025
Q2 		$9.03K Buy
+70
New +$8.72K ﹤0.01% 995

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Twin Peaks Wealth Advisors's BIIB Position: Q1 2026 in Review

Twin Peaks Wealth Advisors opened a new position in Biogen (BIIB) in Q1 2026: 127 shares worth $23.3K. The stake represents 0.01% of the portfolio and ranks #657 among its holdings. This is a return to the name: Twin Peaks Wealth Advisors previously reported a position in BIIB as recently as Q2 2025.

Twin Peaks Wealth Advisors first reported a position in BIIB in Q2 2025 and has held it in 2 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Twin Peaks Wealth Advisors held 127 shares of Biogen worth $23.3K as of Q1 2026.
  • Biogen was a new Twin Peaks Wealth Advisors position in Q1 2026.
  • Biogen made up 0.01% of Twin Peaks Wealth Advisors's portfolio in Q1 2026, its #657 holding.
  • Twin Peaks Wealth Advisors first reported a position in Biogen in Q2 2025 and has held it in 2 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.